Literature DB >> 19535543

Defining incident chronic kidney disease in the research setting: The ARIC Study.

Lori D Bash1, Josef Coresh, Anna Köttgen, Rulan S Parekh, Tibor Fulop, Yaping Wang, Brad C Astor.   

Abstract

Deaths of participants and losses to follow-up pose challenges for defining outcomes in epidemiologic studies. The authors compared several definitions of incident chronic kidney disease (CKD) in terms of incidence, agreement, and risk factor associations. They used data from 14,873 participants in the community-based, multicenter, biracial Atherosclerosis Risk in Communities Study (1987-1999). The estimated glomerular filtration rate (eGFR) was based on serum creatinine at baseline and the 3- and 9-year follow-up visits. Hospitalizations were ascertained continuously. The authors compared 4 definitions of incident CKD: 1) low eGFR (<60 mL/minute/1.73 m(2)); 2) low and declining (> or =25%) eGFR; 3) an increase in serum creatinine (> or =0.4 mg/dL) at 3- or 9-year follow-ups; and 4) CKD-related hospitalization or death. From these definitions, they identified 1,086, 677, 457, and 163 cases, respectively. There was relatively good agreement among definitions 1-3, but definition 4 identified mostly different cases. Risk factor associations were consistent across definitions for hypertension and lipids. Diabetes showed weaker associations with definition 1 (incidence rate ratio = 1.5, 95% confidence interval: 1.2, 1.7) than with definition 4 (incidence rate ratio = 6.3, confidence interval: 4.4, 8.9). Associations with gender differed in direction and magnitude across definitions. Case definition can impact relative risk estimates for CKD risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535543      PMCID: PMC2727177          DOI: 10.1093/aje/kwp151

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  34 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

4.  Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.

Authors:  Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

5.  Insulin resistance and risk of chronic kidney disease in nondiabetic US adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

6.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

7.  Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland.

Authors:  Melanie K Haroun; Bernard G Jaar; Sandra C Hoffman; George W Comstock; Michael J Klag; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

8.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

9.  [Epidemiology of chronic kidney disease in France].

Authors:  Bénédicte Stengel; Cécile Couchoud; Catherine Helmer; Carole Loos-Ayav; Michèle Kessler
Journal:  Presse Med       Date:  2007-08-10       Impact factor: 1.228

10.  The Framingham predictive instrument in chronic kidney disease.

Authors:  Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2007-07-02       Impact factor: 24.094

View more
  62 in total

Review 1.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Racial differences in the incidence of chronic kidney disease.

Authors:  Paul Muntner; Britt Newsome; Holly Kramer; Carmen A Peralta; Yongin Kim; David R Jacobs; Catarina I Kiefe; Cora E Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

3.  Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.

Authors:  Richard D Semba; Jeffrey C Fink; Kai Sun; Anne R Cappola; Mansi Dalal; Candace Crasto; Luigi Ferrucci; Linda P Fried
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

4.  Biomarkers of Vitamin D Status and Risk of ESRD.

Authors:  Casey M Rebholz; Morgan E Grams; Pamela L Lutsey; Andrew N Hoofnagle; Jeffrey R Misialek; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; Chi-Yuan Hsu; Paul L Kimmel; Ramachandran S Vasan; John H Eckfeldt; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2015-10-23       Impact factor: 8.860

5.  Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Authors:  Tamara Isakova; Timothy E Craven; Jungwha Lee; Julia J Scialla; Huiliang Xie; Patricia Wahl; Santica M Marcovina; Robert P Byington; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-24       Impact factor: 8.237

6.  Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.

Authors:  Feijie Wang; Liang Sun; Qi Sun; Liming Liang; Xianfu Gao; Rongxia Li; An Pan; Huaixing Li; Yueyi Deng; Frank B Hu; Jiarui Wu; Rong Zeng; Xu Lin
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

7.  A risk score for chronic kidney disease in the general population.

Authors:  Conall M O'Seaghdha; Asya Lyass; Joseph M Massaro; James B Meigs; Josef Coresh; Ralph B D'Agostino; Brad C Astor; Caroline S Fox
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

8.  High-cost, high-need patients: the impact of reported penicillin allergy.

Authors:  Kimberly G Blumenthal; Nicolas M Oreskovic; Xiaoqing Fu; Fatma M Shebl; Christian M Mancini; Jennifer M Maniates; Rochelle P Walensky
Journal:  Am J Manag Care       Date:  2020-04       Impact factor: 2.229

9.  Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.

Authors:  Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

10.  Elevated plasma tumor necrosis factor-α receptor 2 and resistin are associated with increased incidence of kidney function decline in Chinese adults.

Authors:  Gang Liu; Yueyi Deng; Liang Sun; Xingwang Ye; Pang Yao; Yao Hu; Feijie Wang; Yiwei Ma; Huaixing Li; Yong Liu; Qi Sun; Xu Lin
Journal:  Endocrine       Date:  2015-11-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.